ACE2 enzymatic role in the SARS-CoV-2 activation: a perspective through the evolutionary promiscuity and substrate diversity of enzymes

The SARS-CoV-2 is an RNA B type β-coronavirus that distinguishes itself from previous coronaviruses by its high infectivity and mortality rates. The mechanism of viral entry into the host cell via ACE2 is currently under research. Several proteases have been nominated to activate the virus but iden...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Angela Madalina Lazar
Formato: article
Lenguaje:EN
Publicado: Journal of Ideas in Health 2021
Materias:
R
Acceso en línea:https://doaj.org/article/07a6fe918214474a81b4af54f2969a0f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:07a6fe918214474a81b4af54f2969a0f
record_format dspace
spelling oai:doaj.org-article:07a6fe918214474a81b4af54f2969a0f2021-11-24T12:41:51ZACE2 enzymatic role in the SARS-CoV-2 activation: a perspective through the evolutionary promiscuity and substrate diversity of enzymes10.47108/jidhealth.Vol4.Iss4.1692645-9248https://doaj.org/article/07a6fe918214474a81b4af54f2969a0f2021-11-01T00:00:00Zhttps://www.jidhealth.com/index.php/jidhealth/article/view/169https://doaj.org/toc/2645-9248 The SARS-CoV-2 is an RNA B type β-coronavirus that distinguishes itself from previous coronaviruses by its high infectivity and mortality rates. The mechanism of viral entry into the host cell via ACE2 is currently under research. Several proteases have been nominated to activate the virus but identifying the exact enzyme/enzymes is missing.   Moreover, recent work suggests that TMPRSS2 cannot be the enzyme to cleave the SARS-CoV-2 spike or that multiple proteases contribute to SARS-CoV-2 activation. The multitude of proteases that have been nominated to activate the virus suggests that the consensual identification of the precise, key enzyme is still missing. In this context, we synthesize the current controversies regarding the putative enzymes involved in SARS-CoV-2 infectivity and analyze whether ACE2 could have unexpected enzymatic roles in this process, besides its acknowledged receptor role. We hypothesize that ACE2 plays an enzymatic role as well in SARS-CoV-2 activation. Understanding the exact roles of ACE2 in COVID-19 is capital for the future design of specific, efficient therapies and deserves dedicated research. Our conviction is therefore not "if", “but” "when" will the researchers start to wonder about what is hidden behind the apparent only role of ACE2 as a receptor for SARS-CoV-2. Angela Madalina LazarJournal of Ideas in HealtharticleACE2, SARS-CoV-2, COVID-19, enzymatic activity, enzymatic promiscuity, TMPRSS2, ADAM-17, RomaniaMedicineRMedicine (General)R5-920ENJournal of Ideas in Health, Vol 4, Iss 4 (2021)
institution DOAJ
collection DOAJ
language EN
topic ACE2, SARS-CoV-2, COVID-19, enzymatic activity, enzymatic promiscuity, TMPRSS2, ADAM-17, Romania
Medicine
R
Medicine (General)
R5-920
spellingShingle ACE2, SARS-CoV-2, COVID-19, enzymatic activity, enzymatic promiscuity, TMPRSS2, ADAM-17, Romania
Medicine
R
Medicine (General)
R5-920
Angela Madalina Lazar
ACE2 enzymatic role in the SARS-CoV-2 activation: a perspective through the evolutionary promiscuity and substrate diversity of enzymes
description The SARS-CoV-2 is an RNA B type β-coronavirus that distinguishes itself from previous coronaviruses by its high infectivity and mortality rates. The mechanism of viral entry into the host cell via ACE2 is currently under research. Several proteases have been nominated to activate the virus but identifying the exact enzyme/enzymes is missing.   Moreover, recent work suggests that TMPRSS2 cannot be the enzyme to cleave the SARS-CoV-2 spike or that multiple proteases contribute to SARS-CoV-2 activation. The multitude of proteases that have been nominated to activate the virus suggests that the consensual identification of the precise, key enzyme is still missing. In this context, we synthesize the current controversies regarding the putative enzymes involved in SARS-CoV-2 infectivity and analyze whether ACE2 could have unexpected enzymatic roles in this process, besides its acknowledged receptor role. We hypothesize that ACE2 plays an enzymatic role as well in SARS-CoV-2 activation. Understanding the exact roles of ACE2 in COVID-19 is capital for the future design of specific, efficient therapies and deserves dedicated research. Our conviction is therefore not "if", “but” "when" will the researchers start to wonder about what is hidden behind the apparent only role of ACE2 as a receptor for SARS-CoV-2.
format article
author Angela Madalina Lazar
author_facet Angela Madalina Lazar
author_sort Angela Madalina Lazar
title ACE2 enzymatic role in the SARS-CoV-2 activation: a perspective through the evolutionary promiscuity and substrate diversity of enzymes
title_short ACE2 enzymatic role in the SARS-CoV-2 activation: a perspective through the evolutionary promiscuity and substrate diversity of enzymes
title_full ACE2 enzymatic role in the SARS-CoV-2 activation: a perspective through the evolutionary promiscuity and substrate diversity of enzymes
title_fullStr ACE2 enzymatic role in the SARS-CoV-2 activation: a perspective through the evolutionary promiscuity and substrate diversity of enzymes
title_full_unstemmed ACE2 enzymatic role in the SARS-CoV-2 activation: a perspective through the evolutionary promiscuity and substrate diversity of enzymes
title_sort ace2 enzymatic role in the sars-cov-2 activation: a perspective through the evolutionary promiscuity and substrate diversity of enzymes
publisher Journal of Ideas in Health
publishDate 2021
url https://doaj.org/article/07a6fe918214474a81b4af54f2969a0f
work_keys_str_mv AT angelamadalinalazar ace2enzymaticroleinthesarscov2activationaperspectivethroughtheevolutionarypromiscuityandsubstratediversityofenzymes
_version_ 1718415028465434624